Soleno Therapeutics logo
Soleno Therapeutics SLNO
$ 55.02 0.35%

Quarterly report 2024-Q3
added 11-06-2024

report update icon

Soleno Therapeutics EV/EBITDA Ratio 2011-2024 | SLNO

Annual EV/EBITDA Ratio Soleno Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
0.12 -3.56 -4.2 -1.1 0.183 -0.77 -0.592 1.2 - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
1.2 -4.2 -1.09